Loperamide-Induced Ventricular Tachycardia Storm
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Loperamide is an over-the-counter antilaxative medication with minor opioid properties. For this reason, it has recently become a drug of concern for the Food and Drug Administration due to its potential for abuse. In addition, further apprehension pertaining to its over-the-counter availability has developed due to the recent increase in reported cases of loperamide overdose or prolonged use leading to arrhythmias. We described a rare case of loperamide-induced ventricular tachycardia storm.
References
1.
Battisha A, Sawalha K, Altibi A, Madoukh B, Al-Akchar M, Patel B
. Cardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomes. Heart Fail Rev. 2020; 27(1):93-101.
DOI: 10.1007/s10741-020-09990-4.
View
2.
Eifling M, Razavi M, Massumi A
. The evaluation and management of electrical storm. Tex Heart Inst J. 2011; 38(2):111-21.
PMC: 3066819.
View
3.
Wu P, Juurlink D
. Clinical Review: Loperamide Toxicity. Ann Emerg Med. 2017; 70(2):245-252.
DOI: 10.1016/j.annemergmed.2017.04.008.
View
4.
Zaman J, Agarwal S
. Management of ventricular tachycardia storm. Heart. 2021; 107(20):1671-1677.
DOI: 10.1136/heartjnl-2019-316192.
View
5.
Sawalha K, Abozenah M, Kadado A, Battisha A, Al-Akchar M, Salerno C
. Systematic Review of COVID-19 Related Myocarditis: Insights on Management and Outcome. Cardiovasc Revasc Med. 2020; 23:107-113.
PMC: 7434380.
DOI: 10.1016/j.carrev.2020.08.028.
View